[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Narla et al., 1998 - Google Patents

4-(3'-Bromo-4'hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.

Narla et al., 1998

View PDF
Document ID
688334716925123760
Author
Narla R
Liu X
Myers D
Uckun F
Publication year
Publication venue
Clinical cancer research: an official journal of the American Association for Cancer Research

External Links

Snippet

Abstract The novel quinazoline derivative 4-(3'-bromo-4'-hydroxylphenyl)-amino-6, 7- dimethoxyquinazoline (WHI-P154) exhibited significant cytotoxicity against U373 and U87 human glioblastoma cell lines, causing apoptotic cell death at micromolar concentrations …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in positions 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles

Similar Documents

Publication Publication Date Title
Narla et al. 4-(3'-Bromo-4'hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.
US6316454B1 (en) 6,7-Dimethoxy-4-anilinoquinazolines
US5990141A (en) Treatment of platelet derived growth factor related disorders such as cancers
US6331555B1 (en) Treatment of platelet derived growth factor related disorders such as cancers
TWI468397B (en) Quinazoline derivatives
JP5139083B2 (en) Quinoxaline derivatives as antitumor agents
US8735439B2 (en) Chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same
JP2002540103A (en) Quinazolines and their therapeutic use
You et al. Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy
HU221622B1 (en) Quinazoline derivatives, pharmaceutical compositions comprising same as active ingredient and process for producing them
AU2006201635A1 (en) Novel inhibitors and methods for their preparation
Narla et al. Inhibition of human glioblastoma cell adhesion and invasion by 4-(4'-hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline (WHI-P131) and 4-(3'-bromo-4'-hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline (WHI-P154).
JP2003502412A (en) Melamine derivatives as potent anticancer agents
Narla et al. hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline: A Novel Quinazoline Derivative with Potent Cytotoxic Activity against Human Glioblastoma Cells
Li et al. SAR-guided development of indole-matrine hybrids as potential anticancer agents via mitochondrial stress/cytochrome c/caspase 3 signaling pathway
CN114409636B (en) Quinazolinone compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof
TW201602086A (en) Arylamine substututed quinoxaline and their use as anticancer drugs
JP2002030083A (en) N-(2-chloro-4-{[6-methoxy-7-(3-pyridylmethoxy)-4- quinolyl]oxy}phenyl)-n'-propylurea dihydrochloride
CN111574503A (en) Pyrimidine double aromatic ring derivative epidermal growth factor inhibitor and preparation method and application thereof
Wang et al. Novel thiohydantoin analogues bearing the 1-hydroxyl-2, 2, 2-trifluoro-1-ethyl moiety as androgen receptor inhibitors for the potential treatment of castration resistant prostate cancer
WO2019052046A1 (en) Quinazolines compound, preparation method therefor and application thereof
AU718272B2 (en) Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor
WO2001035952A2 (en) Radiosensitization of human glioblastoma cells by quinazoline compounds
MXPA96002680A (en) Treatment of disorders related to platelet derived growth factor, such commons, using growth receiver inhibitors derived from plate